| Dr Elizabeth L Chmelik, MD | |
|
1660 S Staples St, Ste 150, Corpus Christi, TX 78404-3173 | |
| (361) 800-8155 | |
| (361) 882-2590 |
| Full Name | Dr Elizabeth L Chmelik |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 1660 S Staples St, Corpus Christi, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265464549 | NPI | - | NPPES |
| TXB155616 | Other | WELLMED NETWORKS INC | |
| TXB150355 | Other | WELLMED MEDICAL GROUP PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | M7113 (Texas) | Primary |
| 207Q00000X | Family Medicine | M7113 (Texas) | Secondary |
| Entity Name | Wellmed Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437156486 PECOS PAC ID: 4880657386 Enrollment ID: O20041105000519 |
News Archive
A new study aimed to investigate the susceptibility of adolescents as compared to older adults in the United States during the summer of 2020.
Earlier today, Anthem Blue Cross agreed to a request by the California Department of Insurance to postpone a rate adjustment for individual members in California by two months to allow the Department additional time for review. To avoid confusion for our members, this delay will impact all Anthem individual members regulated at either the state Department of Insurance or the Department of Managed Health Care.
Treating metastatic non-small cell lung cancer patients with the immunotherapy drug pembrolizumab after they've completed locally ablative therapy – meaning all known sites of their cancer were either treated with surgery, radiation, or other definitive treatments – almost tripled the median progression-free survival compared to the historical average.
New research shows one in four chronically ill Australians is skipping healthcare because of high costs.
› Verified 8 days ago
| Entity Name | Wellmed Networks, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386948677 PECOS PAC ID: 6002091261 Enrollment ID: O20110503000555 |
News Archive
A new study aimed to investigate the susceptibility of adolescents as compared to older adults in the United States during the summer of 2020.
Earlier today, Anthem Blue Cross agreed to a request by the California Department of Insurance to postpone a rate adjustment for individual members in California by two months to allow the Department additional time for review. To avoid confusion for our members, this delay will impact all Anthem individual members regulated at either the state Department of Insurance or the Department of Managed Health Care.
Treating metastatic non-small cell lung cancer patients with the immunotherapy drug pembrolizumab after they've completed locally ablative therapy – meaning all known sites of their cancer were either treated with surgery, radiation, or other definitive treatments – almost tripled the median progression-free survival compared to the historical average.
New research shows one in four chronically ill Australians is skipping healthcare because of high costs.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth L Chmelik, MD 1660 S Staples St, Ste 150, Corpus Christi, TX 78404-3173 Ph: (361) 800-8155 | Dr Elizabeth L Chmelik, MD 1660 S Staples St, Ste 150, Corpus Christi, TX 78404-3173 Ph: (361) 800-8155 |
News Archive
A new study aimed to investigate the susceptibility of adolescents as compared to older adults in the United States during the summer of 2020.
Earlier today, Anthem Blue Cross agreed to a request by the California Department of Insurance to postpone a rate adjustment for individual members in California by two months to allow the Department additional time for review. To avoid confusion for our members, this delay will impact all Anthem individual members regulated at either the state Department of Insurance or the Department of Managed Health Care.
Treating metastatic non-small cell lung cancer patients with the immunotherapy drug pembrolizumab after they've completed locally ablative therapy – meaning all known sites of their cancer were either treated with surgery, radiation, or other definitive treatments – almost tripled the median progression-free survival compared to the historical average.
New research shows one in four chronically ill Australians is skipping healthcare because of high costs.
› Verified 8 days ago
Veena Kommera Reddy, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4254 S Alameda St, Corpus Christi, TX 78412 Phone: 361-500-4351 Fax: 888-711-1008 | |
Christina Rawana, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3315 S Alameda St, Corpus Christi, TX 78411 Phone: 361-884-2904 Fax: 361-857-0572 | |
Abraham G Ayala, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1660 S Staples St, Ste 150, Corpus Christi, TX 78404 Phone: 361-800-8155 Fax: 361-882-2590 | |
James M Dee, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 5846 Wooldridge Rd, Corpus Christi, TX 78414 Phone: 361-994-8979 Fax: 361-994-8966 | |
Dr. Joyce Marie Jackson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 600 Elizabeth St, Corpus Christi, TX 78404 Phone: 832-599-8081 Fax: 832-327-7868 | |
Dr. Danielle Marie Kleppe, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3533 S Alameda St, Corpus Christi, TX 78411 Phone: 361-694-5000 Fax: 361-694-5317 |